Bauro, Myrel B.
HRN: 25-27-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/12/2024
06/19/2024
IV
300mg
IV
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes